Multiplex Testing Solutions for COVID-19 and Influenza
In today’s dynamic healthcare environment, the need for accurate and efficient diagnostics is crucial, especially during surges of influenza and COVID-19. The Fisher Healthcare channel offers a robust portfolio of point-of-care assays based on molecular and PCR technology, as well as reader systems, to help healthcare providers detect these illnesses using cost-effective multiplex testing kits and solutions.
Explore a curated selection that provides dependable detection of respiratory pathogens, supports streamlined clinical workflows, and offers greater cost control and convenience.
*ID NOW Influenza A & B 2 test kits sold separately. ID NOW software update to version 7.1 required for sequential workflow capability.